Drug interactions
Glimepiride-pioglitazone + Lonapegsomatropin
Severity: Moderate
Glimepiride-pioglitazone and Lonapegsomatropin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Growth hormone reduces insulin sensitivity and may raise blood glucose, antagonizing the effects of glimepiride and pioglitazone. Patients with diabetes may need antidiabetic dose increases after starting growth hormone.
What this interaction means in plain words
Glimepiride-pioglitazone and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Glimepiride-pioglitazone belongs to Endocrine; Lonapegsomatropin belongs to Endocrine.
Why it happens
Growth hormone induces insulin resistance, opposing antidiabetic drug action.
What to do
Monitor glucose and HbA1c after initiation and dose changes, and adjust antidiabetic therapy as required.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Glimepiride-pioglitazone and Lonapegsomatropin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Glimepiride-pioglitazone
Other interactions of Lonapegsomatropin
Frequently asked questions
Can I take Glimepiride-pioglitazone with Lonapegsomatropin?
MediHelp rates the interaction as moderate. Glimepiride-pioglitazone and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Growth hormone reduces insulin sensitivity and may raise blood glucose, antagonizing the effects of glimepiride and pioglitazone. Patients with diabetes may need antidiabetic dose increases after starting growth hormone.
How serious is the interaction between Glimepiride-pioglitazone and Lonapegsomatropin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glucose and HbA1c after initiation and dose changes, and adjust antidiabetic therapy as required.
What other medicines interact with Glimepiride-pioglitazone?
MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin aspart. The full list is on the Glimepiride-pioglitazone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
